Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xing-gui Chen
BIRB796, the Inhibitor of P38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells
PLoS ONE
Multidisciplinary
Related publications
P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)
Science-Business eXchange
P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)
Science-Business eXchange
Metabolism of a Novel Skepinone L-Like P38 Mitogen-Activated Protein Kinase Inhibitor
MedChemComm
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Pharmaceutical Science
Drug Discovery
Human P38 Mitogen-Activated Protein Kinase Inhibitor Drugs Inhibit Plasmodium Falciparum Replication
Experimental Parasitology
Medicine
Parasitology
Infectious Diseases
Immunology
The Proteasome Inhibitor Bortezomib Enhances ATRA-Induced Differentiation of Neuroblastoma Cells via the JNK Mitogen-Activated Protein Kinase Pathway
PLoS ONE
Multidisciplinary
Efficacy of a Nitrogen-Containing Bisphosphonate, Minodronate, in Conjunction With a P38 Mitogen Activated Protein Kinase Inhibitor or Doxorubicin Against Malignant Bone Tumor Cells
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Insulin Resistance Enhances the Mitogen-Activated Protein Kinase Signaling Pathway in Ovarian Granulosa Cells
PLoS ONE
Multidisciplinary
FAM172A Protein Promotes the Proliferation of Human Papillary Thyroid Carcinoma Cells via the P38 Mitogen-Activated Protein Kinase Pathway
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Contrast Bath-Induced Neurite Outgrowth in PC12m3 Cells via the P38 Mitogen-Activated Protein Kinase Pathway
Heliyon
Multidisciplinary